Innovation Fund Denmark grants Industrial PhD Project

May 11, 2016

IO Biotech has been granted an Industrial PhD project entitled ‘Characterisation of a PD-L1-based cancer vaccine in vivo’ from Innovation Fund Denmark. The Industrial PhD will be performed in collaboration with Department of Immunology and Microbiology, University of Copenhagen, between June 2016 and June 2019.

Other news

IO Biotech, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

IO Biotech, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

November 9, 2021
IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 with KEYTRUDA® (pembrolizumab) as First-Line Treatment in Metastatic Melanoma Patients in a Phase 3 Trial

IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 with KEYTRUDA® (pembrolizumab) as First-Line Treatment in Metastatic Melanoma Patients in a Phase 3 Trial

September 14, 2021
back to news overview